Found 52 Enz. Inhib. hit(s) with all data for entry = 50006388 TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
3D Structure (crystal)TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 79nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 570nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 680nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 720nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 760nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 790nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 790nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 820nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 860nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 880nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.12E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.25E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.29E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.49E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.56E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.68E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.91E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.23E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.27E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.35E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.38E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.52E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 2.53E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 3.27E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 4.27E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 4.32E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 4.74E+3nMAssay Description:Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobili...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 5.11E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 5.67E+3nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.06E+4nMAssay Description:Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.07E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.16E+4nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.18E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.27E+4nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: 1.53E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility ...More data for this Ligand-Target Pair
